Australia markets closed

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.56+0.41 (+6.67%)
At close: 04:00PM EDT
6.67 +0.11 (+1.68%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
3,845
1,979
1,979
Operating expenses
Research development
7,136
7,771
7,592
6,157
6,680
Selling general and administrative
6,379
6,468
8,336
3,109
2,207
Total operating expenses
13,515
14,239
15,929
9,259
8,317
Operating income or loss
-13,515
-14,239
-12,084
-7,281
-6,339
Interest expense
-
83.025
6,753
3,439
292.062
Total other income/expenses net
4,205
7,327
15,804
-4,264
-
Income before tax
-9,393
-6,996
-3,034
-14,983
-6,630
Income tax expense
-799.471
-1,089
-1,720
-1,408
-1,172
Income from continuing operations
-8,594
-5,907
-1,314
-13,576
-5,458
Net income
-8,594
-5,907
-1,314
-13,576
-5,458
Net income available to common shareholders
-8,594
-5,907
-1,314
-13,576
-5,458
Basic EPS
-56.60
-19.20
-38.20
-694.49
-194.52
Diluted EPS
-56.60
-19.20
-38.20
-694.49
-194.52
Basic average shares
104.714
308.921
34.36
19.548
28.058
Diluted average shares
104.714
308.921
34.36
19.548
28.058